Tandem Diabetes Care (TNDM) Total Current Liabilities (2013 - 2026)

Tandem Diabetes Care has reported Total Current Liabilities for 14 years, with the latest figure at $248.0 million in Q1 2026.

• For the quarter ending Q1 2026, Total Current Liabilities fell 13.96% year-over-year to $248.0 million; the trailing twelve-month figure through Mar 2026 stood at $248.0 million (down 13.96% YoY), and the FY2025 full-year result was $242.7 million, down 1.75% from the prior year.
• Total Current Liabilities for Q1 2026 stood at $248.0 million, up from $242.7 million in the prior quarter.
• The five-year high for Total Current Liabilities was $288.2 million in Q1 2025, with the low at $131.8 million in Q1 2022.
• Historically, Total Current Liabilities has averaged $209.5 million across 5 years, with a median of $195.3 million in 2023.
• Annual changes were most pronounced in 2025 — Total Current Liabilities surged 49.34% — and 2026, when it declined 13.96%.
• Tandem Diabetes Care's Total Current Liabilities stood at $165.3 million in 2022, then rose by 18.13% to $195.3 million in 2023, then rose by 26.52% to $247.0 million in 2024, then decreased by 1.75% to $242.7 million in 2025, then rose by 2.16% to $248.0 million in 2026.
• The last three Total Current Liabilities figures came in at $248.0 million (Q1 2026), $242.7 million (Q4 2025), and $252.5 million (Q3 2025), per Business Quant data.